Search Result "AMG145"

PCSK9 and LDLR The Yin-Yang in the Cellular Uptake of Cholesterol

Journal: Current Hypertension Reviews
Volume: 9 Issue: 4 Year: 2013 Page: 310-323
Author(s): Enrique Morales-Villegas

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and LDL Lowering in the Contemporary Management of Dyslipidemia

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 11 Issue: 4 Year: 2013 Page: 281-288
Author(s): Maryna Popp Switzer,Azikiwe C. Nwosu,Zinnia San Juan,Debabrata Mukherjee

Review Article

Three Musketeers for Lowering Cholesterol: Statins, Ezetimibe and Evolocumab

Journal: Current Medicinal Chemistry
Volume: 28 Issue: 5 Year: 2021 Page: 1025-1041
Author(s): Qian Xu,Yiming Deng,Jun Xiao,Xiangrui Liu,Min Zhou,Zhong Ren,Juan Peng,Yaling Tang,Zhisheng Jiang,Zhihan Tang,Lushan Liu

Novel Therapeutic Strategies for the Homozygous Familial Hypercholesterolemia

Journal: Recent Patents on Cardiovascular Drug Discovery
Volume: 8 Issue: 2 Year: 2013 Page: 143-150
Author(s): Giuliana Mombelli,Chiara Pavanello

General Review Article

The LDL-Receptor and its Molecular Properties: From Theory to Novel Biochemical and Pharmacological Approaches in Reducing LDL-cholesterol

Journal: Current Medicinal Chemistry
Volume: 27 Issue: 2 Year: 2020 Page: 317-333
Author(s): Dimitrios Petroglou,Ilias Kanellos,Christos Savopoulos,Georgia Kaiafa,Anastasios Chrysochoou,Panagiotis Skantzis,Stylianos Daios,Apostolos I. Hatzitolios,Georgios Giannoglou

Hypolipidaemic Drug Treatment: Yesterday is Not Gone Yet, Today is Challenging and Tomorrow is Coming Soon; let us Combine them all

Journal: Current Pharmaceutical Design
Volume: 20 Issue: 4 Year: 2014 Page: 6350-6357
Author(s): Vasilios G. Athyros, Konstantinos Tziomalos, Asterios Karagiannis, Dimitri P. Mikhailidis

Review Article

PCSK9 Inhibitors: Novel Therapeutic Strategies for Lowering LDLCholesterol

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 19 Issue: 2 Year: 2019 Page: 165-176
Author(s): Yan Wang,Zhao-Peng Liu

Familial Hypercholesterolemia: Etiology, Diagnosis and New Treatment Options

Journal: Current Pharmaceutical Design
Volume: 20 Issue: 4 Year: 2014 Page: 6220-6229
Author(s): Ioanna Gouni-Berthold, Heiner K. Berthold

PCSK9 Inhibition - A Novel Mechanism to Treat Lipid Disorders?

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 2 Year: 2013 Page: 3869-3877
Author(s): Maciej Banach, Manfredi Rizzo, Milan Obradovic, Giuseppe Montalto, Jacek Rysz, Dimitri P. Mikhailidis, Esma R. Isenovic

Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Inhibitors in the Treatment of Hypercholesterolemia and other Pathologies

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 1 Year: 2013 Page: 3161-3172
Author(s): Nabil G. Seidah

Previous   Next

Go To   Results 1 - 1 of 11

Apply Filters

Volume Years
Article Type
    Publication Title
      Subject Title

Content Type


© 2025 Bentham Science Publishers | Privacy Policy